The Transformative Potential of Biomarkers, Tuesday, August 23, 2022, 1 p.m. ET. This virtual forum will explore how biomarkers are changing cancer research and care to benefit patients with cancer.
Register TodayCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreAn Ambitious Effort Aims to Boost Diversity in Clinical Trials: The program is training early-stage physicians to increase health equity and inclusion in clinical trials.
Read Leading DiscoveriesMore than 236,000 people living in the United States were diagnosed with lung cancer this year. Learn about the prevention, screening, and treatment options for lung cancer.
Learn MorePalliative care isn’t just for the end of life; it can benefit patients at any stage of their cancer treatment. Learn how palliative care helped multiple myeloma patient Margaret McGill get back on her feet in AACR Stories.
Read AACR StoriesDespite tools to prevent cervical cancer, many women, particularly Black and Hispanic women and other underserved populations, are being diagnosed with the disease.
Read MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research (AACR) has a lasting impact.
Donate NowAACR grants support researchers domestically and abroad at every career stage, representing a global commitment to cancer prevention, early detection, interception, and cure.
The report provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn MoreThe AACR and its more than 50,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreFor the woman with Lynch syndrome, a delayed colonoscopy highlighted the impact of the pandemic on cancer screening.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2020, to July 31, 2021
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2018
Learn More